Succeeder(SH:688338) Sou Hu Cai Jing·2025-08-15 12:34Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Saikohide, a company in the medical device industry, which has a current stock price of 27.8 yuan and a market capitalization of 2.951 billion yuan [1] - Saikohide's rolling price-to-earnings (PE) ratio is 27.92, significantly lower than the industry average of 56.58 and the median of 39.97, indicating a relatively undervalued position within its sector [1][2] - The company has seen an increase in shareholder numbers, with 6,725 shareholders as of March 31, 2025, up by 1,118 from the previous count, and an average holding value of 352,800 yuan per shareholder [1] Group 2 - Saikohide specializes in the research, development, production, and sales of diagnostic instruments, reagents, and consumables in the field of thrombosis and hemostasis [1] - The company’s main products include automated testing devices, coagulation analyzers, blood rheology analyzers, and various coagulation and blood rheology reagents and consumables [1] - In the latest quarterly report for Q1 2025, Saikohide reported a revenue of 68.6393 million yuan, a year-on-year decrease of 9.47%, and a net profit of 23.1329 million yuan, down 23.98%, with a gross margin of 62.49% [1]